Singapore markets close in 3 hours 12 minutes

Medexus Pharmaceuticals Inc. (MEDXF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
2.2599-0.0502 (-2.17%)
At close: 03:59PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Cash flows from operating activities
Net income
3,270
1,221
-2,879
-28,264
-4,397
Depreciation & amortisation
5,985
6,081
6,145
5,978
3,706
Deferred income taxes
-5,875
-6,262
-941
-3,237
-790.4386
Stock-based compensation
1,174
1,216
1,883
1,270
1,385
Change in working capital
-11,658
-15,262
4,730
182
-1,491
Accounts receivable
-11,300
-8,236
4,430
-3,505
-7,258
Inventory
-3,177
-1,987
-6,660
-9
997.0385
Other working capital
6,412
-1,806
-8,894
-5,717
-2,464
Other non-cash items
14,712
13,606
12,223
9,816
6,236
Net cash provided by operating activities
6,786
-1,444
-1,180
5,038
-1,622
Cash flows from investing activities
Investments in property, plant and equipment
-374
-362
-7,714
-10,755
-841.9123
Acquisitions, net
-1,779
-1,359
-482
-952
-27,935
Net cash used for investing activities
-2,153
-1,721
-8,196
-11,704
-28,571
Cash flows from financing activities
Debt repayment
-24,696
-24,724
-164
-369
-313.778
Common stock issued
-
-
0
22,635
0
Common stock repurchased
-
-
-
-
-2,636
Dividends paid
0
0
0
0
0
Other financing activities
-
-
-
-297
-342.6879
Net cash used provided by (used for) financing activities
3,913
6,405
663
18,683
14,602
Net change in cash
8,546
3,240
-8,713
12,017
-15,592
Cash at beginning of period
7,285
10,018
18,704
5,233
20,593
Cash at end of period
15,831
13,069
10,018
18,704
5,235
Free cash flow
Operating cash flow
6,786
-1,444
-1,180
5,038
-1,622
Capital expenditure
-374
-362
-7,714
-10,755
-841.9123
Free cash flow
6,412
-1,806
-8,894
-5,717
-2,464